Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:04 pm Sale | 13G | ELI LILLY AND CO LLY | VANGUARD GROUP INC | 71,604,696 7.54% | -1,825,167 (-2.49%) | View |
| 2024-02-09 09:26 am Sale | 13G | ELI LILLY AND CO LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,540,105 5.43% | -289,768 (-0.56%) | View |
| 2024-01-29 3:26 pm Sale | 13G | ELI LILLY AND CO LLY | BlackRock Inc. BLK | 64,376,027 6.8% | -1,091,766 (-1.67%) | View |
| 2024-01-26 4:25 pm Sale | 13G | ELI LILLY AND CO LLY | LILLY ENDOWMENT INC | 99,768,810 10.51% | -3,180,000 (-3.09%) | View |
| 2023-08-14 4:30 pm Purchase | 13D | SIGILON THERAPEUTICS INC N SGTX | ELI LILLY & Co LLY | 100 100% | 100 (New Position) | View |
| 2023-07-07 4:33 pm Sale | 13D | SIGILON THERAPEUTICS INC SGTX | ELI LILLY & Co LLY | 1,008,830 40.3% | -1,735,613 (-63.24%) | View |
| 2023-02-10 10:42 am Sale | 13G | ELI LILLY AND CO LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,829,873 5.25% | -58,582 (-0.11%) | View |
| 2023-02-09 11:19 am Purchase | 13G | ELI LILLY AND CO LLY | VANGUARD GROUP INC | 73,429,863 7.73% | 4,168,109 (+6.02%) | View |
| 2023-01-31 5:52 pm Purchase | 13G | ELI LILLY AND CO LLY | BlackRock Inc. BLK | 65,467,793 6.9% | 1,590,770 (+2.49%) | View |
| 2023-01-27 4:57 pm Unchanged | 13G | PRECISION BIOSCIENCES INC DTIL | ELI LILLY & Co LLY | 3,762,190 3.4% | 0 (Unchanged) | View |
| 2023-01-27 4:41 pm Unchanged | 13G | AC IMMUNE SA SHS ACIU | ELI LILLY & Co LLY | 3,615,328 4.3% | 0 (Unchanged) | View |
| 2023-01-25 4:14 pm Sale | 13G | ELI LILLY AND CO LLY | LILLY ENDOWMENT INC | 102,948,810 10.83% | -4,515,000 (-4.20%) | View |
| 2022-12-23 4:39 pm Purchase | 13G | PROQR THERAPEUTICS N.V. PRQR | ELI LILLY & Co LLY | 13,371,562 16.6% | 9,381,586 (+235.13%) | View |
| 2022-12-01 4:11 pm Sale | 13D | AKOUOS INC AKUS | ELI LILLY & Co LLY | 100 100% | -9,639,089 (-100.00%) | View |
| 2022-10-27 4:31 pm Purchase | 13D | AKOUOS INC AKUS | ELI LILLY & Co LLY | 9,639,189 25.5% | 9,639,189 (New Position) | View |
| 2022-02-11 07:46 am Sale | 13G | ELI LILLY AND CO LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,888,455 5.42% | -123,696 (-0.24%) | View |
| 2022-02-10 4:29 pm Purchase | 13G | FORMA THERAPEUTICS HLDGS INC FMTX | ELI LILLY & Co LLY | 339,191 0.7% | 339,191 (New Position) | View |
| 2022-02-10 4:26 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | ELI LILLY & Co LLY | 1,593,997 3.5% | 1,593,997 (New Position) | View |
| 2022-02-10 4:21 pm Unchanged | 13G | AVIDITY BIOSCIENCES INC RNA | ELI LILLY & Co LLY | 2,319,396 4.9% | 0 (Unchanged) | View |
| 2022-02-10 4:16 pm Purchase | 13G | LEAP THERAPEUTICS INC LPTX | ELI LILLY & Co LLY | 3,151,605 3.5% | 519,384 (+19.73%) | View |